Unaudited Interim Condensed Consolidated Statements of Changes in Shareholders' Equity (Deficit) - USD ($) $ in Thousands	Total	Common Stock	Exchangeable Shares	Proportionate Voting Shares	Preferred Stock Series A Convertible Preferred Stock	Preferred Stock Series B Convertible Preferred Stock	Preferred Stock Series C Convertible Preferred Stock	Preferred Stock Series D Convertible Preferred Stock	Common Shares Equivalent	Additional Paid In Capital	Accumulated Other Comprehensive Income (Loss)	Accumulated Deficit	Non-Controlling Interest
Balance at Dec. 31, 2020	$ (13,316)									$ 305,138	$ (3,662)	$ (318,594)	$ 3,802
Balance, shares at Dec. 31, 2020		79,526,785	38,890,571	76,307	14,258	710			209,692,379
Shares issued - stock option, warrant and RSU exercises	33,323									33,323
Shares issued - stock option, warrant and RSU exercises, shares		3,782,457					123	1,315	5,219,569
Shares, options and warrants issued- acquisitions	34,427									34,427
Shares, options and warrants issued - acquisitions, shares		3,464,870							3,464,870
Shares issued- liability settlement	80									80
Shares issued- liability settlement, shares		8,000							8,000
Private placement net of share issuance costs	173,477									173,477
Private placement net of share issuance costs, shares		18,115,656							18,115,656
Shares issued- conversion, shares		78,358,768		(76,307)	(550)	(100)	(87)	(1,315)
Share-based compensation expense	13,393									13,393
Options and warrants expired/forfeited										(547)		547
Investment in NJ partnership	(50,000)									(48,594)			(1,406)
Conversion of convertible debt	5,656									5,656
Conversion of convertible debt, shares		1,284,221							1,284,221
Capital (distribution)/contribution	174												174
Net (loss) income for the period	12,062											9,594	2,468
Foreign currency translation	3,469										3,469
Balance at Sep. 30, 2021	212,745									516,353	(193)	(308,453)	5,038
Balance, shares at Sep. 30, 2021		184,540,757	38,890,571		13,708	610	36		237,784,695
Balance at Dec. 31, 2020	(13,316)									305,138	(3,662)	(318,594)	3,802
Balance, shares at Dec. 31, 2020		79,526,785	38,890,571	76,307	14,258	710			209,692,379
Investment in NJ partnership	(1,406)
Balance at Dec. 31, 2021	228,954									535,418	2,823	(314,654)	5,367
Balance, shares at Dec. 31, 2021		190,930,800	38,890,571		13,708	610	36		244,175,394
Balance at Jun. 30, 2021	202,742									560,085	(1,552)	(363,375)	4,480
Balance, shares at Jun. 30, 2021		184,402,803	38,890,571		13,708	610			237,610,922
Shares issued - stock option, warrant and RSU exercises	155									155
Shares issued - stock option, warrant and RSU exercises, shares		134,954					36		170,773
Shares issued- liability settlement	23									23
Shares issued- liability settlement, shares		3,000							3,000
Share-based compensation expense	5,178									5,178
Options and warrants expired/forfeited										(494)		494
Investment in NJ partnership	(50,000)									(48,594)			(1,406)
Capital (distribution)/contribution	557												557
Net (loss) income for the period	55,835											54,428	1,407
Foreign currency translation	(1,745)										(1,745)
Balance at Sep. 30, 2021	212,745									516,353	(193)	(308,453)	5,038
Balance, shares at Sep. 30, 2021		184,540,757	38,890,571		13,708	610	36		237,784,695
Balance at Dec. 31, 2021	228,954									535,418	2,823	(314,654)	5,367
Balance, shares at Dec. 31, 2021		190,930,800	38,890,571		13,708	610	36		244,175,394
Shares issued - stock option, warrant and RSU exercises	25,779									25,779
Shares issued - stock option, warrant and RSU exercises, shares		9,589,868							9,589,868
Shares, options and warrants issued- acquisitions	330,983									330,983
Shares, options and warrants issued - acquisitions, shares		56,153,162	13,504,500						69,657,662
Shares issued- liability settlement	264									264
Shares issued- liability settlement, shares		101,203							101,203
Shares issued- conversion, shares		1,085,819			(1,050)		(36)
Share-based compensation expense	10,524									10,524
Options and warrants expired/forfeited										(25,670)		25,670
Capital (distribution)/contribution	(3,724)												(3,724)
Net (loss) income for the period	(312,829)											(316,352)	3,523
Foreign currency translation	(1,129)										(1,129)
Balance at Sep. 30, 2022	278,822									877,298	1,694	(605,336)	5,166
Balance, shares at Sep. 30, 2022		257,860,852	52,395,071		12,658	610			323,524,127
Balance at Jun. 30, 2022	579,981									889,961	(1,063)	(315,132)	6,215
Balance, shares at Jun. 30, 2022		252,707,325	52,395,071		12,658	610			318,370,600
Shares issued - stock option, warrant and RSU exercises	36									36
Shares issued - stock option, warrant and RSU exercises, shares		253,140							253,140
Shares, options and warrants issued- acquisitions	7,926									7,926
Shares, options and warrants issued - acquisitions, shares		4,803,184							4,803,184
Shares issued- liability settlement	242									242
Shares issued- liability settlement, shares									97,203
Shares issued- conversion, shares		97,203
Share-based compensation expense	2,705									2,705
Options and warrants expired/forfeited										(23,008)		23,008
Capital (distribution)/contribution	(3,840)									(564)			(3,276)
Net (loss) income for the period	(310,985)											(313,212)	2,227
Foreign currency translation	2,757										2,757
Balance at Sep. 30, 2022	$ 278,822									$ 877,298	$ 1,694	$ (605,336)	$ 5,166
Balance, shares at Sep. 30, 2022		257,860,852	52,395,071		12,658	610			323,524,127